רופילק 300

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

ANTI-D IMMUNOGLOBULINS

Mevcut itibaren:

CSL BEHRING LTD., ISRAEL

ATC kodu:

J06BB01

Farmasötik formu:

תמיסה להזרקה

Kompozisyon:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Uygulama yolu:

תוך-שרירי, תוך-ורידי

Reçete türü:

מרשם נדרש

Tarafından üretildi:

CSL BEHRING AG, SWITZERLAND

Terapötik grubu:

ANTI-D (RH) IMMUNOGLOBULIN

Terapötik alanı:

ANTI-D (RH) IMMUNOGLOBULIN

Terapötik endikasyonlar:

Prophylaxis of Rh (D) immunisation in Rh (D)-negative women: Anti-D immune globulin is administered for the prevention of Rh (D) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. Treatment is not necessary when it is assured that the child or the father are Rh (D)- negative. Criteria for a rhesus-incompatible pregnancy and the administration of anti-D immune globulin are : a) the mother is Rh (D) -negative b) the child is either Rh (D)-positive Rh (D)weak - positive or its rhesus type is not known. Routine antepartum prophylaxis : To prevent Rh (D) immunisation due to spontaneous fetomaternal haemorrhage (FMH) during the last trimester of pregnancy. Postpartum prophylaxis To prevent Rh (D) immunisation of the Rh (D)-negative mother following delivery of a Rh (D)-positive child. Complications of pregnancy: Interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

Yetkilendirme tarihi:

2023-02-28